{
  "id": 1549298,
  "title": "Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™",
  "url": "https://urgent.news/2026/08/17/nanochon-receives-regulatory-approval-from-panamas-ministry-of-health",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-17T19:45:30.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/nanochon-receives-regulatory-approval-from-panamas-ministry-of-health-to-initiate-first-in-human-clinical-study-of-chondrograft"
  },
  "original_language": "en",
  "account": null,
  "summary": "WASHINGTON — Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance of Chondrograft™ […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}